COMMENTARY: Plasma exchange led to a higher rate of renal recovery than intravenous methylpredisolone in severe vasculitis

Lionaki, Sofia
January 2008
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p11
Academic Journal
The author comments on the study which examines the effect of cyclophosphamide and oral prednisolone in treating patients with severe vasculitis. Study suggests that when people with severe vasculitis are being treated with methylprednisolone, adding plasma exchange to treatment should be considered. However, the author states that it should be considered only in patients with advanced severe disease because benefits are unlikely in those with less-severe disease.


Related Articles

  • Plasma exchange led to a higher rate of renal recovery than intravenous methylpredisolone in severe vasculitis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p11 

    The article presents a study which examines the effect of cyclophosphamide and oral prednisolone in treating patients with severe vasculitis. According to the study, patients with severe vasculitis who received cyclophosphamide and prednisolone, plasma exchange led to greater renal recovery than...

  • Diagnostic approach to patients with suspected vasculitis. Suresh, E. // Postgraduate Medical Journal;Aug2006, Vol. 82 Issue 970, p483 

    Vasculitis presents several diagnostic challenges. Firstly, patients could present with protean clinical manifestations with a wide spectrum ranging from isolated cutaneous vasculitis to multisystem involvement. Secondly, there are several medical conditions that could mimic the presentation of...

  • Childhood vasculitis and plasma exchange. Wright, Elizabeth; Dillon, Michael J.; Tullus, Kjell // European Journal of Pediatrics;Feb2007, Vol. 166 Issue 2, p145 

    Introduction: A retrospective review of therapeutic plasma exchange (TPE) for vasculitis of any form during the period 1993-2003 was carried out in our unit.Subjects and Methods: The case histories of 32 children undergoing TPE were analysed to determine short-term...

  • Management of anesthesia in henoch schonlein purpura: a case report. Koca, Erdinc // Journal of Turgut Ozal Medical Center;2016, Vol. 23 Issue 4, p457 

    Henoch schonlein purpura (HSP) is the most common kind of acute small-vessel vasculitis especially affecting children. It is initiated by deposition of immune complexes as responses to infections such as group A streptococci, mycoplasma, Epstein -Barr, and Varicella zoster. HSP is characterized...

  • Treatment of FSGS with plasma exchange and immunadsorption. Franke, Doris; Zimmering, Miriam; Wolfish, Norman; Ehrich, Jochen H. H.; Filler, Guido // Pediatric Nephrology;Sep2000, Vol. 14 Issue 10/11, p965 

    In primary focal and segmental glomerulosclerosis (FSGS) renal prognosis is poor if no remission of proteinuria can be achieved with treatment. Currently, most children with FSGS are treated with cyclosporine and steroids after establishing steroid resistance, and approximately 60% of patients...

  • Neurological aspects of uremia: An overview. Tyler, H. Richard // Kidney International Supplement;Jan1975, Issue 2, pS-188 

    In this article the author focuses on the neurological aspects of uremia. Cramping tends to occur in patients who were water-intoxicated with more frequency than in those with other electrolyte disorders. Although it is characteristic to see cramping as a major complaint of the active patient...

  • Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Millet, Arnaud; Pederzoli-Ribeil, Magali; Guillevin, Loïc; Witko-Sarsat, Véronique; Mouthon, Luc // Postgraduate Medical Journal;May2014, Vol. 90 Issue 1063, p290 

    Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a heterogeneous group of diseases corresponding to necrotising inflammation of small vessels with a wide range of clinical presentations. At least two of the diseases are believed to exhibit a common ground of...

  • Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Ateş, Aşkın; Karaaslan, Yaşar; Aksaray, Sebahat // Clinical Rheumatology;Apr2007, Vol. 26 Issue 4, p499 

    The objective of this study was to determine the diagnostic value for rheumatoid arthritis (RA) of antibodies to cyclic citrullinated peptides (anti-CCP) in patients with early arthritis and vasculitis. Sixty-four adult patients with early arthritis and disease duration of less than 4 months...

  • Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis. de Groot, Kirsten; Harper, Lorraine; Jayne, David R. W.; Suarez, Luis Felipe Flores; Gregorini, Gina; Gross, Wolfgang L.; Luqmani, Rashid; Pusey, Charles D.; Rasmussen, Niels; Sinico, Renato A.; Tesar, Vladimir; Vanhille, Philippe; Westman, Kerstin; Savage, Caroline O. S. // Annals of Internal Medicine;5/19/2009, Vol. 150 Issue 10, p670 

    Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)—associated vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission. Design: Randomized, controlled trial. Random assignments...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics